- Home
- CMPS vs GHG Comparison
CMPS vs GHG Comparison
Compare CMPS & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- GHG
- Stock Information
- Founded
- CMPS 2020
- GHG 2004
- Country
- CMPS United Kingdom
- GHG China
- Employees
- CMPS N/A
- GHG N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- CMPS Health Care
- GHG Consumer Discretionary
- Exchange
- CMPS Nasdaq
- GHG Nasdaq
- Market Cap
- CMPS 280.2M
- GHG 289.4M
- IPO Year
- CMPS 2020
- GHG 2018
- Fundamental
- Price
- CMPS $4.41
- GHG $2.50
- Analyst Decision
- CMPS Strong Buy
- GHG
- Analyst Count
- CMPS 7
- GHG 0
- Target Price
- CMPS $30.67
- GHG N/A
- AVG Volume (30 Days)
- CMPS 842.0K
- GHG 8.6K
- Earning Date
- CMPS 10-31-2024
- GHG 11-21-2024
- Dividend Yield
- CMPS N/A
- GHG 3.86%
- EPS Growth
- CMPS N/A
- GHG N/A
- EPS
- CMPS N/A
- GHG 0.28
- Revenue
- CMPS N/A
- GHG $201,166,731.00
- Revenue This Year
- CMPS N/A
- GHG N/A
- Revenue Next Year
- CMPS N/A
- GHG $8.78
- P/E Ratio
- CMPS N/A
- GHG $9.31
- Revenue Growth
- CMPS N/A
- GHG N/A
- 52 Week Low
- CMPS $4.00
- GHG $2.31
- 52 Week High
- CMPS $12.75
- GHG $4.10
- Technical
- Relative Strength Index (RSI)
- CMPS 41.38
- GHG 36.52
- Support Level
- CMPS $4.00
- GHG $2.60
- Resistance Level
- CMPS $4.91
- GHG $2.71
- Average True Range (ATR)
- CMPS 0.26
- GHG 0.10
- MACD
- CMPS 0.06
- GHG -0.01
- Stochastic Oscillator
- CMPS 45.05
- GHG 0.00
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.